Evidence map›Paper›PMID 33335927›Full record

ArticleBioMed research international2020

ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.

Dan Wang, Hua Gao, Yanxia Li, Sen Jiang, Xinling Yang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Case Report: NovelFrontiers in genetics · 2025
    Article
  2. Article
  3. ATP13A2 (PARK9) and basal ganglia function.Frontiers in neurology · 2023
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dan WangDepartment of Neurology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, China.ORCID https://orcid.org/0000-0002-8374-4130
Hua GaoDepartment of Neurology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, China.ORCID https://orcid.org/0000-0003-4925-5306
Yanxia LiDepartment of Rehabilitation, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, China.ORCID https://orcid.org/0000-0002-3602-5600
Sen JiangDepartment of Neurology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, China.ORCID https://orcid.org/0000-0003-2668-3180
Xinling YangDepartment of Neurology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, China.ORCID https://orcid.org/0000-0002-4517-0500
Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the

methodsFour

resultsOnly one Han patient harbored the AG genotype of the rs147277743 SNV, indicating a frequency of 0.46% in the Han population. In addition, this SNV was not associated with PD risk. The rs2076603 SNV was correlated with PD development, and the A allele in particular was significantly different across ethnicity and age. The rs56367069 and rs151117874 SNVs were not detected in the entire cohort.

conclusion

Indexed as

Genetic VariationAgedAllelesAsian PeopleCase-Control StudiesChinaCohort StudiesFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedParkinson DiseaseProton-Translocating ATPasesATP13A2 protein, humanProton-Translocating ATPases

Identifiers

PMID33335927
PMCPMC7723492
OpenAlexW3108514557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.